SB65 (2017) Detail

Relative to vaccines administered by pharmacists.


CHAPTER 149

SB 65 - FINAL VERSION

 

04/27/2017   1646EBA

2017 SESSION

17-0930

01/08

 

SENATE BILL 65

 

AN ACT relative to vaccines administered by pharmacists.

 

SPONSORS: Sen. Giuda, Dist 2; Sen. Bradley, Dist 3; Sen. Soucy, Dist 18; Rep. D. Sullivan, Hills. 8

 

COMMITTEE: Health and Human Services

 

-----------------------------------------------------------------

 

ANALYSIS

 

This bill adds certain vaccines to the law which allows licensed pharmacists to administer vaccines.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

04/27/2017   1646EBA 17-0930

01/08

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Seventeen

 

AN ACT relative to vaccines administered by pharmacists.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

149:1  Vaccines Administered by Pharmacists; Vaccines Added.  Amend RSA 318:16-b to read as follows:

318:16-b  Pharmacist Administration of Vaccines.  A pharmacist may administer influenza vaccines to the general public and a pharmacist may administer pneumococcal [and], varicella zoster, hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccines to individuals 18 years of age or older, provided all of the criteria in this section have been met.  The pharmacist shall:

I.  Hold a current license to practice as a pharmacist in New Hampshire.

II.  Possess at least $1,000,000 of professional liability insurance coverage.

III.  In order to administer influenza, pneumococcal, [and] varicella zoster, hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccines, have completed training specific to the administering of the respective vaccines that includes programs approved by the Accreditation Council for Pharmacy Education (ACPE) or curriculum-based programs from an ACPE-accredited college of pharmacy or state or local health department programs or programs recognized by the board.

IV.  Provide to the board evidence of compliance with paragraphs I-III.

V.  Provide notice to the primary care provider, when designated by the patient, of the administration of the pneumococcal [and], varicella zoster, hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccines.

VI.  Maintain a record of administration of pneumococcal [and], varicella zoster, hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccinations for each individual as required by state and federal law.

149:2  Vaccines Administered by Pharmacists; Vaccines Added.  Amend RSA 318:16-b to read as follows:

318:16-b  Pharmacist Administration of Vaccines.  A pharmacist or pharmacy intern under the direct supervision of an immunizing pharmacist may administer influenza vaccines to the general public and a pharmacist or pharmacy intern may administer pneumococcal [and], varicella zoster, hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccines to individuals 18 years of age or older, provided all of the criteria in this section have been met.  The pharmacist and pharmacy intern shall:

I.  Hold a current license to practice as a pharmacist or be registered as a pharmacy intern under RSA 318:15-b in New Hampshire.

II.  Possess at least $1,000,000 of professional liability insurance coverage.

III.  In order to administer influenza, pneumococcal, [and] varicella zoster, hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccines, have completed training specific to the administering of the respective vaccines that includes programs approved by the Accreditation Council for Pharmacy Education (ACPE) or curriculum-based programs from an ACPE-accredited college of pharmacy or state or local health department programs or programs recognized by the board.

IV.  Provide to the board evidence of compliance with paragraphs I-III.

V.  Provide notice to the primary care provider, when designated by the patient, of the administration of the pneumococcal [and], varicella zoster, hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccines.

VI.  Maintain a record of administration of pneumococcal [and], varicella zoster, hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccinations for each individual as required by state and federal law.

149:3  Contingency.  If SB 150 of the 2017 regular legislative session becomes law, section 1 of this act shall not take effect and section 2 of this act shall take effect January 1, 2018.  If SB 150 of the regular legislative session does not become law, section 1 of this bill shall take effect January 1, 2018 and section 2 of this act shall not take effect.

149:4  Effective Date.  

I.  Sections 1 and 2  of this act shall take effect as provided in section 3 of this act.

II.  The remainder of this act shall take effect upon its passage.

 

Approved: June 16, 2017

Effective Date:

I. Sections 1 and 2 effective as provided in section 3.

II. Remainder effective June 16, 2017

Links

SB65 at GenCourtMobile

Action Dates

Date Body Type
March 21, 2017 Senate Hearing
March 29, 2017 Senate Floor Vote
April 11, 2017 House Hearing
April 25, 2017 House Exec Session
May 4, 2017 House Floor Vote

Bill Text Revisions

SB65 Revision: 1699 Date: June 19, 2017, 11:14 a.m.
SB65 Revision: 1700 Date: May 10, 2017, 5:36 p.m.
SB65 Revision: 1701 Date: Jan. 24, 2017, 10:20 a.m.

Docket


June 16, 2017: II. Remainder Effective 06/16/2017


: I. Sections 1 and 2 of this act shall take effect as provided in Section 3


June 16, 2017: Signed by the Governor on 06/16/2017; Chapter 0149


May 18, 2017: Enrolled (In recess 05/18/2017); SJ 18


May 18, 2017: Enrolled 05/18/2017 HJ 16 P. 8


April 27, 2017: Enrolled Bill Amendment # 2017-1646e Adopted, VV, (In recess of 04/27/2017); SJ 16


May 4, 2017: Enrolled Bill Amendment # 2017-1646e: AA VV 05/04/2017 HJ 15 P. 47


May 4, 2017: Ought to Pass: MA RC 281-76 05/04/2017 HJ 15 P. 23


: Minority Committee Report: Inexpedient to Legislate


May 4, 2017: Majority Committee Report: Ought to Pass for 05/04/2017 (Vote 14-7; RC) HC 22 P. 8


April 25, 2017: Executive Session: 04/25/2017 09:30 AM LOB 205


April 11, 2017: Public Hearing: 04/11/2017 11:00 AM LOB 205


March 23, 2017: Introduced 03/23/2017 and referred to Health, Human Services and Elderly Affairs HJ 11 P. 27


March 29, 2017: Ought to Pass: MA, VV; OT3rdg; 03/29/2017; SJ 11


March 29, 2017: Committee Report: Ought to Pass, 03/29/2017; SC 16


March 21, 2017: Hearing: 03/21/2017, Room 101, LOB, 01:00 pm; SC 15


Jan. 5, 2017: Introduced 01/05/2017 and Referred to Health and Human Services; SJ 4